Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02087163 · ClinicalTrials.gov registry record · NA

The Use of Clear Aligners With Movement Enhancement Techniques

A NA study of Malocclusion, sponsored by Align Technology.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02087163: Completed NA study of Malocclusion, sponsored by Align Technology.

NCT02087163 is a NA study of Malocclusion that has completed, run by Align Technology. The registered enrollment target is 90 participants, roughly in line with the 94-participant average among 6 other Malocclusion trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02087163, a NA study of Malocclusion, has completed, sponsored by Align Technology.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use clear aligners to measure tooth movement and length of treatment.

Primary Outcome

Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Tooth movement change will be measured as the number of millimeters of tooth movement per aligner.

Conditions Studied

Interventions

  • DEVICE Movement Enhancement Technique
  • DEVICE Clear Aligner

Study Locations (1)

California

  • Align Technology, Inc. - San Jose

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2014-02
Est. Completion 2019-04
Phase NA
Align Technology

5 total trials

What the finished NCT02087163 record still lists

NCT02087163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, roughly in line with the 94-participant average among 6 other Malocclusion trials with a reported enrollment target.

The record links to 1 condition, with Malocclusion appearing as the primary indexed condition, and to 2 interventions - of which Movement Enhancement Technique is the first listed.

NCT02087163 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02087163 about?

NCT02087163 is a clinical study titled "The Use of Clear Aligners With Movement Enhancement Techniques". The purpose of this study is to use clear aligners to measure tooth movement and length of treatment.

What is the current status of trial NCT02087163?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2014-02. Estimated completion is 2019-04.

What conditions does trial NCT02087163 study?

This clinical trial studies the following conditions: Malocclusion.

What interventions are being tested in trial NCT02087163?

The interventions under investigation include: Movement Enhancement Technique (DEVICE), Clear Aligner (DEVICE).

Who is sponsoring clinical trial NCT02087163?

This trial is sponsored by Align Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02087163 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malocclusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02087163, the US trial registry maintained by the National Library of Medicine. NCT02087163 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.